MANNKIND CORP Restructuring Reserve
MANNKIND CORP (MNKD) had Restructuring Reserve of $1.38 million as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2017-03-16
- 2016-12-31: Restructuring Reserve $1.38M.
- 2016-09-30: Restructuring Reserve $3.19M.
- 2015-12-31: Restructuring Reserve $3.03M; Restructuring Reserve as first filed $3.00M.
- 2015-09-30: Restructuring Reserve $3.15M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2016-12-31 | $1.38M 10-K · filed 2017-03-16 | |
| 2016-09-30 | $3.19M 10-Q · filed 2016-11-09 | |
| 2015-12-31 | $3.03M 10-K · filed 2017-03-16 | $3.00M 10-K · filed 2016-03-15 |
| 2015-09-30 | $3.15M 10-Q · filed 2016-11-09 | |
| 2014-12-31 | $300.00K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |